Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells

Journal of Cellular Physiology

Volumn 218, Issue 1, 2009, Pages 135-145

  Qisheng, T U ^a   Zhang, J I N ^a,b   Amanda, F I X ^a   Brewer, Erika ^a   Yi Ping, L I ^c   Zhang, Zhi Yuan ^d   Chen, Jake ^a  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

^c FORSYTH INSTITUTE   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE SIALOPROTEIN; CATHEPSIN K; OSTEOPROTEGERIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG; PRIMER DNA; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METASTASIS; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; ANIMAL; BONE TUMOR; BREAST TUMOR; CELL DIFFERENTIATION; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METASTASIS; NUCLEOTIDE SEQUENCE; OSTEOLYSIS; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; OSTEOCLASTS; OSTEOLYSIS; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS;

EID: 58149157660     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21576     Document Type: Article

References (45)

1. Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, Van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC. 2003. Osteoblast-related transcription factors Runx2 (Cbfal/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63:2631-2637.
2. Barnes GL, Hebert KE, Kamal M, Javed A, Einhorn TA, Lian JB, Stein GS, Gerstenfeld LC. 2004. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Res 64:4506-45l3.
3. Bellahcene A, Merville MP, Castronovo V. l994. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 54:2823-2826.
4. Bellahcene A, Kroll M, Liebens F, Castronovo V. l996a. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res ll:665-670.
5. Bellahcene A, Menard S, Bufalino R, Moreau L, Castronovo V. l996b. Expression ofbone sialoprotein in primaryhuman breastcancer is associated with poor survival. Int J Cancer 69:350-353.
6. Bellahcene A, Bonjean K, Fohr B, Fedarko NS, Robey FA, Young MF, Fisher LW, Castronovo V. 2000. Bone sialoprotein mediates human endothelial cell attachmentand migration and promotes angiogenesis. Circ Res 86:885-89l.
7. Bianco P, Fisher LW, Young MF, Termine JD, RobeyPG. l99l. Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int 49:42l-426.
8. Byzova TV, Kim W, Midura RJ, Plow EF. 2000.Activation of integrin alpha(V)beta(3)regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254:299-308.
9. Chen J, Thomas HF, Jin H, Jiang H, Sodek J. l996. Expression of rat bone sialoprotein promoter in transgenic mice. J Bone Miner Res ll:654-664.
10. Chen J, Rodriguez JA, Barnett B, Hashimoto N, Tang J, Yoneda T. 2003. Bone sialoprotein promotes tumor cell migration in both in vitro and in vivo models. Connect Tissue Res 44:279-284.
11. Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G. l999. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bonemetastasis. Clin Cancer Res 5:39l4-39l9.
12. Fisher LW, McBride OW, ermine JD, Young MF. l990. Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J Biol Chem 265:2347-235l.
13. Fisher LW, Jain A, Tayback M, Fedarko NS. 2004. Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res l0:850l-85ll.
14. Ganss B, Kim RH, Sodek J. l999. Bone sialoprotein. Crit Rev Oral Biol Med l0:79-98.
15. Hiraga T, Williams PJ, Ueda A, Tamura D, Yoneda T. 2004. Zoledronic acid inhibits visceral metastases in the 4Tl/luc mouse breast cancer model. Clin Cancer Res l l0:4559-4567.
16. Hiraga T, Hata K, Ikeda F, Kitagaki J, Fujimoto-Ouchi K, Tanaka Y, Yoneda T. 2005. Preferential inhibition of bone metastases by 5′-deoxy-5 fluorouridine and capecitabine in the 4Tl/luc mouse breast cancer model. Oncol Rep l4:695-699.
17. Ida-Yonemochi H, Ishibashi O, Sakai H, Saku T. 2004. Recruitment of osteoclasts in the mandible of osteopetrotic (op/op) mice. Eur J Oral Sci ll2:l48-l55.
18. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. l998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:l65-l76.
19. Lane NE, Yao W, Nakamura MC, Humphrey MB, Kimmel D, Huang X, Sheppard D, Ross FP, Teitelbaum SL. 2005. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state. J Bone Miner Res 20:58-66.
20. Lees RL, Sabharwal VK, Heersche JN. 2001. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films. Bone 28:l87-l94.
21. YP, Chen W. l999. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression. J Bone Miner Res l4:487-499.
22. L, Zhu J,Tu Q,Yamauchi M, Sodek J, Karsenty G, Tang J, Chen J. 2005. An in vivomodel to study osteogenic gene regulation: Targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter. J Bone Miner Res 20:l403-l4l3.
23. Mastro AM, Gay CV, Welch DR. 2003. The skeleton as a unique environment for breast cancer cells. Clin Exp Metastasis 20:275-284.
24. Mohla S, Weilbacher KN, Cher ML, Oyajobi BO, Poznak CV, Clohisy DR. 2003. Third North American Symposium on Skeletal Complications of Malignancy: Summary of the scientific sessions. Cancer 97:7l9-725.
25. Nam JS, Suchar AM, Kang MJ, Stuelten CH, Tang B, Michalowska AM, Fisher LW, Fedarko NS, Jain A, Pinkas J, Lonning S, Wakefield LM. 2006. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res 66:6327-6335.
26. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY. 2007. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med l3:62-69.
27. Paz J, Wade K, Kiyoshima T, Sodek J, Tang J, Tu Q, Yamauchi M, Chen J. 2005. Tissue- and bone cell-specific expression of bone sialoprotein is directed by a 9.0 kb promoter in transgenic mice. Matrix Biol 24:34l-352.
28. Raynal C, Delmas PD, Chenu C. l996. Bonesialoprotein stimulates in vitro bone resorption. Endocrinology l37:2347-2354.
29. Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT. 2002. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 30:40-47.
30. Reddi AH, Roodman D, Freeman C, Mohla S. 2003. Mechanisms oftumor metastasis to the bone: Challenges and opportunities. J Bone Miner Res l8:l90-l94.
31. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA. l993. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 268:990l-9907.
32. Ruoslahti E.l996.RGD and other recognition sequences for integrins. Ann Rev Cell Develop Biol l2:697-7l5.
33. Sanjay A, Houghton A, Neff L, Di Domenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC, Baron R. 200l. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclastmotility. J Cell Biol l52:l8l-l95.
34. Shankar G, Gadek TR, Burdick DJ, Davison I, Mason WT, Horton MA. l995. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: Integrin-dependent and -independent actions. Exp cell Res 2l9:364-37l.
35. Sugatani T, Hruska KA. 2005.Aktl/Akt2 and mammalian target of rapamycin/Bim playcritical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280:3583-3589.
36. Sung V, Stubbs JT, III, Fisher L, Aaron AD, Thompson EW. l998. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol l76:482-494.
37. Valverde P, Tu Q, Chen J. 2005. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res 20:l669-l679.
38. Valverde P, Zhang J, Fix A, Zhu J, Ma L, Tu Q, Chen J. 2008. Overexpression of bone sialoprotein leads toan uncoupling of bone formation and boneresorption in mice. J Bone Miner Res [Epub ahead of print].
39. Waltregny D, Bellahcene A, de Leval X, Florkin B, Weidle U, Castronovo V. 2000. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 15:834-843.
40. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S,Tomoyasu A, Yano K, Goto M, Murakami A,Tsuda E, MorinagaT, Higashio K, Udagawa N,Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Nat Acad Sci 95:3597-3602.
41. YonedaT. 1998. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-245.
42. Zhang JH, Tang J, Wang J, Ma W, Zheng W, Yoneda T, Chen J. 2003. Over-expression of bone sialoprotein enhances bonemetastasis ofhuman breastcancer cells in amouse model. IntJ Oncol 23:1043-1048.
43. ZhangJH, WangJ, TangJ, BarnettB, Dickson J, Hahsimoto N, Williams P, Ma W, ZhengW, Yoneda T, Pageau S, Chen J. 2004. Bone sialoprotein promotes bone metastasis ofa non-bone-seeking clone ofhuman breast cancer cells. Anticancer Res 24:1361-1368.
44. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D. 2002. Bone
45. morphogenetic protein receptor signalingis necessaryfor normal murine postnatal bone formation. J Cell Biol 157:1049-1060.